NSE seeks clarification on Premarin cream suspension news

Compliance

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.7%1-day move

₹4700.10

prior close

₹4555.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1+0.2+0.2+0.5-2.7-2.2-1.7-1.1-1.4—————

Up moveDown movePending

AI summary

NSE has asked Pfizer to clarify a news report that it has stopped selling Premarin vaginal cream in India. Premarin is a hormone-based product used for menopause symptom relief. The exchange is awaiting an official response from the company on whether the suspension is true and what it means for its menopause care business in India.

Likely market impact

Clarification pending; short-term uncertainty around the Premarin news may affect stock sentiment until Pfizer responds.